Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.32 |
---|---|
High | 0.32 |
Low | 0.215 |
Bid | -- |
Offer | -- |
Previous close | 0.300 |
Average volume | 1.54k |
---|---|
Shares outstanding | 1.39m |
Free float | 1.16m |
P/E (TTM) | -- |
Market cap | 348.67k USD |
EPS (TTM) | -18.59 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 19:55 BST.
More ▼
- NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- NexImmune Announces $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- NexImmune, Yale, and JDRF Extend Research Partnership for Type 1 Diabetes
- NexImmune Announces Presentations at The Society for Immunotherapy of Cancer’s 38th Annual Meeting
- NexImmune Announces 1-for-25 Reverse Stock Split
More ▼